AMYPAD's Avatar

AMYPAD

@imi-amypad.bsky.social

Research initiative aiming to improve the understanding, diagnosis & management of Alzheimer's disease. Our project was funded by @ihieurope.bsky.social https://amypad.eu/

107 Followers  |  124 Following  |  19 Posts  |  Joined: 04.02.2025  |  1.9591

Latest posts by imi-amypad.bsky.social on Bluesky

Post image

📣 #AAIC25 is around the corner!

Whether you’ll be on-site in Toronto or joining online, don’t miss the AMYPAD presentations 👇

For more information about the conference, please visit: aaic.alz.org

25.07.2025 10:48 — 👍 1    🔁 0    💬 0    📌 0
Preview
Utility, Costs and Cost‐Utility of Amyloid‐PET in the Diagnostic Process of Memory Clinic Patients: A Trial‐Based Economic Evaluation From AMYPAD‐DPMS Background Amyloid positron emission tomography (PET) is instrumental in achieving an accurate diagnosis and may help to limit health-seeking behavior. Currently, amyloid-PET is not routinely used i...

📢 NEW AMYPAD paper out in European Journal of Neurology assessing the cost-utility of early versus no amyloid-PET in the diagnostic work-up of memory clinic patients after 6 months. @ihieurope.bsky.social

Congratulations to all authors 👏

doi.org/10.1111/ene....

24.06.2025 07:57 — 👍 0    🔁 1    💬 0    📌 0
Post image

This past two days, we hosted the Euro-PAD symposium to discuss the latest advancements in neuroimaging and biomarkers for #Alzheimer’s disease, as well as to share updates from the Euro-PAD initiative over the past year. ⤵️

www.barcelonabeta.org/en/news/news...

18.06.2025 08:09 — 👍 3    🔁 1    💬 1    📌 0
Post image

📣Yesterday and today, the Euro-PAD community convened in Barcelona for a scientific symposium hosted by @barcelonabeta.bsky.social.

👉Almost 100 participants gathered to discuss the latest advancements in neuroimaging and biomarkers for Alzheimer’s disease!

amypad.eu/news/recent-...

17.06.2025 06:44 — 👍 4    🔁 1    💬 0    📌 0
Post image Post image Post image

This morning, before the symposium, we held two parallel workshops, one led by #BBRC researchers focused on fluid biomarkers and the other led by
@acealzheimercenter.com focused on clinical trials

16.06.2025 14:56 — 👍 4    🔁 2    💬 0    📌 0
Post image

Today and tomorrow we are hosting the EuroPAD 2025 symposium!

#EuroPAD seeks to enhance and extend late-stage biomarker cohorts focused on Alzheimer’s, with the specific aim of establishing the most extensive and deeply phenotyped longitudinal cohort of at-risk individuals.

16.06.2025 14:53 — 👍 4    🔁 1    💬 1    📌 0

📢 JUST PUBLISHED: Paper in @natrevdrugdiscov.nature.com on how to maximise #RegulatoryImpact from public-private partnerships, co-authored by IHI’s Nathalie Seigneuret. Check out 3 examples to follow from C-Path & @imi-amypad.bsky.social
👇 Read it below 👇
#IHITransformingHealth #RegulatoryScience

12.06.2025 09:13 — 👍 2    🔁 1    💬 0    📌 0
Delivering regulatory impact from consortium-based projects Multiple consortia have been established in the past two decades with the aim of tackling roadblocks in the development of medical products, often by developing new tools to support decision making by...

📣New paper out highlighting lessons learned that could help maximise the regulatory impact of consortium-based projects.

C-Path and AMYPAD are featured as examples of projects that have achieved regulatory successes

👉https://www.nature.com/articles/d41573-025-00098-8

16.06.2025 09:19 — 👍 1    🔁 0    💬 0    📌 0
Preview
Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study - European Journal of Nucle... Purpose Amyloid PET imaging is capable of measuring brain amyloid load in vivo. The aim of this study is to assess the relationship of the baseline amyloid with its accumulation over time and with cog...

NEW paper out entitled "Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study"

Congratulations to all authors 👏

Check it out now⤵️

link.springer.com/article/10.1...

28.04.2025 07:37 — 👍 0    🔁 1    💬 0    📌 0
Post image

📢Exciting news! We're pleased to announce that the AMYPAD raw dataset is now available for data access requests on the Alzheimer's Disease Data Initiative's Workbench!

➡️ Visit the AMYPAD website for more information: amypad.eu/data/

22.04.2025 12:09 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

👉Leo Pieperhoff presented findings from the AMYPAD PHNS study at #ADPD2025 today!

The harmonised data are available on the #ADWorkbench of the Alzheimer’s Disease Data Initiative. Interested to learn more? Visit Booth 16 of the Alzheimer’s Disease Data Initiative at #ADPD2025!

02.04.2025 12:35 — 👍 0    🔁 0    💬 0    📌 0
Post image

🧠 #ADPD2025 DAY 2!

Join us in Room Hall F2 today at 13:50 for the symposium “WHITE MATTER ALTERATIONS”.

Leonard Pieperhoff will be presenting AMYPAD results “Grey/White Matter Contrast Alterations Precede Amyloid Positivity and Atrophy Markers.”

Don’t miss his insightful presentation 🙌

02.04.2025 09:08 — 👍 1    🔁 0    💬 0    📌 0
Post image Post image Post image Post image

🚨#ADPD2025 is officially underway!

This morning Mario Tranfa, Luigi Lorenzini and Emma Luckett presented data from the AMYPAD, EPAD and Euro-PAD consortiums!

Natàlia Vilor Tejedor also presented the #ADWorkbench at the session hosted by the Alzheimer's Disease Data Initiative!

01.04.2025 11:48 — 👍 1    🔁 0    💬 0    📌 0
Post image

✨ Today marks the start of #ADPD2025 in Vienna!

If you're attending the conference, don’t miss the AMYPAD, EPAD and EUROPAD-related talks.

We hope to see you there to catch up on our latest advancements 🙌

01.04.2025 09:08 — 👍 2    🔁 2    💬 0    📌 0
Post image Post image

👉 Earlier today, we were pleased to present insights from the AMYPAD project at #ECCN2025 during a satellite symposium, sponsored by Life Molecular Imaging!

Thanks to everyone who joined us and contributed to the discussion ☺️

25.03.2025 13:54 — 👍 2    🔁 0    💬 0    📌 0
Preview
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease Amyloid-β (Aβ) positron emission tomography (PET) imaging and cerebrospinal fluid (CSF) biomarkers are now established tools in the diagnostic workup of patients with Alzheimer's disease (AD), and t...

📣 Check out this new article providing a comprehensive review of the pathologic processes reflected by Aβ-PET and CSF biomarkers, their performance, and their current and future applications and contexts of use.

Congratulations to all authors 👏

doi.org/10.1002/alz....

24.03.2025 14:15 — 👍 4    🔁 2    💬 0    📌 0
Post image

🌟Good morning #ECCN25!

Join us tomorrow for the AMYPAD satellite symposium "What does AMYPAD study reveal about centiloid relevance for the future clinical setting?"

We're looking forward to seeing you!

24.03.2025 10:08 — 👍 1    🔁 0    💬 0    📌 0
Post image

If you are attending next week #ECCN25 in Madrid, don’t miss the AMYPAD satellite symposium on Tuesday, 25th March at 12:30.

This session will explore the AMYPAD study's impact on centiloid relevance and its implications for future clinical practices.

17.03.2025 10:08 — 👍 1    🔁 0    💬 0    📌 0
Post image

✨The #ADPD2025 conference is just one month away in Vienna!

AMYPAD, EPAD and EUROPAD will be presenting their latest insights in Alzheimer's disease research! We can't wait to see you there! 🙌

03.03.2025 10:08 — 👍 3    🔁 0    💬 0    📌 0
Post image

The 13th European Conference on Clinical Neuroimaging #ECCN25 will be held in Madrid next month!

We're pleased to held a symposium exploring the AMYPAD study's impact on centiloid relevance & its implications for future clinical practices.

We can’t wait to see you in Madrid!

24.02.2025 10:08 — 👍 1    🔁 1    💬 0    📌 0
Post image Post image

📢 The latest edition of the AMYPAD newsletter was released last month! If you missed it, don't worry, catch up with the latest updates and ongoing efforts. The newsletter also includes new papers and an exclusive interview with Emma Luckett!

Read the newsletter here ⤵️
https://buff.ly/40YvZGB

10.02.2025 10:08 — 👍 2    🔁 0    💬 0    📌 0
Post image

📢 Check out this recent opinion piece on the use of Centiloid threshold for anti-amyloid therapy published in The Journal of Prevention of Alzheimer's Disease.

Many AMYPAD collaborators are acknowledged for sharing their input on the topic!

doi.org/10.1016/j.tj...

04.02.2025 11:56 — 👍 3    🔁 1    💬 0    📌 0
Post image

👋 Hello Bluesky! We're a collaborative initiative aiming to improve the understanding, diagnosis & management of #Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

We continue to make significant strides despite being in the @ihieurope.bsky.social post-funding period⤵️

amypad.eu

04.02.2025 11:51 — 👍 8    🔁 3    💬 0    📌 0

@imi-amypad is following 20 prominent accounts